CMS Bails Out Heart-Assist Device R&D, Covers Comparative LVAD Studies

CMS' decision to grant coverage to trials investigating left-ventricular assist devices has resolved much of the financial uncertainty surrounding LVAD development in recent years

More from Archive

More from Medtech Insight